Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 13, 244 (2007)
doi:10.1038/nm0307-244
Skin safety
Charlotte Schubert
While basic researchers tease out the critical cytokines behind psoriasis, clinicians have not been idle. A monoclonal antibody that recognizes both IL-12 and IL-23 has been making its way through clinical trials; the most recent results were reported February 8 in the New England Journal of Medicine ( 356, 580–592).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Skin safetyNature Medicine News and Views (01 Mar 2007)
Historical Research HighlightsNature Medicine News and Views (01 Dec 2004)
RESEARCH
DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxinInternational Journal of Obesity Scientific Correspondence
Carnitine metabolism during exercise in patients on chronic hemodialysisKidney International Original Article
See all 5 matches for Research